Results 181 to 190 of about 37,330 (229)

Will the introduction of β-lactamase inhibitors alter the adverse event profile of parent penicillins antibiotics? a pharmacovigilance study based on amoxicillin-clavulanate and ampicillin-sulbactam. [PDF]

Front Pharmacol
He Y, Liao Y, Xiao G, Zhou D, Huang L, Wei S.   +5 more
europepmc   +1 more source

<i>In vitro</i> activity of new combinations of β-lactam and β-lactamase inhibitors against the <i>Mycobacterium tuberculosis</i> complex. [PDF]

Microbiol Spectr, 2023
Economou Lundeberg E, Andersson V, Wijkander M, Groenheit R, Mansjö M, Werngren J, Cortes T, Barilar I, Niemann S, Merker M, Köser CU, Davies Forsman L.   +11 more
europepmc   +1 more source

A calorimetric study of β-sultams and β-lactams

The hydrolytic degradation of a series of β-sultams and β-lactams was investigated using isothermal microcalorimetry (IMC), to determine kinetic and enthalpic data.
Naz, Summia
core  

Restoring ceftolozane susceptibility: a role for diazabicyclooctane β-lactamase inhibitors? [PDF]

Antimicrob Agents Chemother
Dorazio AJ, Kline EG, Squires KM, Pogue JM, Van Tyne D, Shields RK.   +5 more
europepmc   +1 more source

Role of β-lactamase inhibitors on cefiderocol activity against carbapenem-resistant Acinetobacter species. [PDF]

Int J Antimicrob Agents, 2023
Mezcord V, Wong O, Pasteran F, Corso A, Tolmasky ME, Bonomo RA, Ramirez MS.   +6 more
europepmc   +1 more source

Harder than Metal: Challenging Antimicrobial Resistance with Metallo-β-lactamase Inhibitors. [PDF]

J Med Chem
De Falco A, Alfano AI, Cutarella L, Mori M, Brindisi M.   +4 more
europepmc   +1 more source

A Review of <i>β</i>-Lactamase Inhibitors in Clinical Use and Development: Mechanisms, Spectrum, and Therapeutic Applications. [PDF]

Int J Microbiol
Gourabi MJR, Nikoo A, Khanbabaei B, Kargar M, Fayyazi A, Mousavi SMJ, Aghdaee A, Hashemi A, Sharahi JY.   +8 more
europepmc   +1 more source

Challenges of Carbapenem-Resistant <i>Enterobacteriaceae</i> in the Development of New β-Lactamase Inhibitors and Antibiotics. [PDF]

Antibiotics (Basel)
Leroux P, Bornet C, Bolla JM, Cohen A.
europepmc   +1 more source

Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry. [PDF]

Int J Mol Sci
Santi N, Piccirilli A, Corsini F, Taracila MA, Perilli M, Bonomo RA, Fini F, Prati F, Caselli E.   +8 more
europepmc   +1 more source

Sustainable Joullié-Ugi and Continuous Flow Implementation Led to Novel Captopril-Inspired Broad-Spectrum Metallo-β-Lactamase Inhibitors. [PDF]

J Med Chem
Alfano AI, Pelliccia S, Barone S, Cutarella L, Cancade SMI, Baia V, Cassese E, Russomanno P, Messano N, Frank D, Weizel L, Rotter MJ, Brunst S, Wichelhaus TA, Proschak E, Tedesco D, Mori M, Docquier JD, Summa V, Brindisi M.   +19 more
europepmc   +1 more source